Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $721.2900 (1.04%) ($710.2800 - $728.0900) on Thu. Dec. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.63% (three month average) | RSI | 29 | Latest Price | $721.2900(1.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(50%) DIA(32%) IWD(28%) SPLV(28%) IVW(26%) | Factors Impacting REGN price | REGN will decline at least -0.815% in a week (0% probabilities). EDOC(-7%) ARKG(-6%) ARKK(-4%) BOTZ(-3%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.815% (StdDev 1.63%) | Hourly BBV | 0 () | Intraday Trend | 0.6% | | | |
|
Resistance Level | $738.99 | 5 Day Moving Average | $720.47(0.11%) | 10 Day Moving Average | $724.49(-0.44%) | 20 Day Moving Average | $738.99(-2.4%) | To recent high | -5.9% | To recent low | 4.6% | Market Cap | $76.477b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |